Quinazolinedione Derivatives as Potential Anticancer Agents Through Apoptosis Induction in MCF-7

Area of Science:

• Oncology
• Molecular Biology
• Pharmacology

Background:

• Breast cancer is a major global health concern, with existing treatments facing challenges like drug resistance and side effects.
• Novel therapeutic strategies are crucial to improve patient outcomes and overcome treatment limitations.

Purpose of the Study:

• To evaluate the potential of quinazolinedione derivatives to induce apoptosis in human breast cancer cells (MCF-7).
• To investigate the underlying molecular mechanisms of apoptosis induction by these compounds.

Main Methods:

• Cytotoxicity was assessed using the MTT assay.
• Apoptosis was quantified via Annexin V-PE/7AAD staining and flow cytometry.
• Apoptosis-related protein expression (caspase-9, p53, Bcl-2, p-Akt) was analyzed using multiplexed immunoassays.

Main Results:

• Two quinazolinedione derivatives demonstrated significant, dose-dependent reduction in MCF-7 cell viability.
• Apoptosis was primarily induced via the intrinsic pathway, confirmed by increased caspase-9 and p53 levels and decreased Bcl-2 and p-Akt.
• The compounds exhibited potent cytotoxic and apoptosis-inducing effects.

Conclusions:

• Quinazolinedione derivatives are effective in inducing apoptosis in breast cancer cells.
• These compounds represent promising candidates for developing new breast cancer therapeutics.
• Further research into their mechanisms and clinical potential is warranted.